Literature DB >> 12234883

Incidence of iris colour change in latanoprost treated eyes.

M A Teus1, E Arranz-Márquez, P Lucea-Suescun.   

Abstract

AIMS: To determine the incidence of increased iris pigmentation in eyes treated with chronic latanoprost. This is an observational, cohort study.
METHODS: The anterior segments of both eyes of 43 patients with glaucoma were photographed after unilateral latanoprost therapy. Two independent, masked observers analysed the slides of both eyes of the study participants, and compared the iris pigmentation of both eyes of each patient using a stereo viewer.
RESULTS: 30 patients (69.7%) had a definite acquired iridial anisochromia; 15 patients (50%) had increased superficial iris pigmentation with a "granular" appearance (type 1 change), and 15 patients (50%) had an increased "stromal pigmentation"-that is, the affected iris appeared darker than the fellow eye, but without a "granular" appearance (type 2 change).
CONCLUSION: The incidence of increased iris pigmentation induced by latanoprost is much higher than previously reported. The high prevalence of mixed iris colour found in this population and the fact that the patients studied were undergoing unilateral therapy may explain these results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234883      PMCID: PMC1771317          DOI: 10.1136/bjo.86.10.1085

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Refractive, keratometric, and topographic determination of astigmatic axis after penetrating keratoplasty.

Authors:  S Kaye; M Batterbury; A Fisher
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Surgery for glaucoma in the 21st century.

Authors:  P T Khaw; A P Wells; K S Lim
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

3.  Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.

Authors:  N G Lindquist; B S Larsson; J Stjernschantz
Journal:  Exp Eye Res       Date:  1999-10       Impact factor: 3.467

4.  [The fine structure of melanocytes in the human iris].

Authors:  C E Dieterich
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1972

5.  A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

Authors:  P Watson; J Stjernschantz
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

6.  Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.

Authors:  C B Camras
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

7.  Melanocytes and iris color. Electron microscopic findings.

Authors:  P D Imesch; C D Bindley; Z Khademian; B Ladd; R Gangnon; D M Albert; I H Wallow
Journal:  Arch Ophthalmol       Date:  1996-04

8.  Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

Authors:  C B Camras; A Alm; P Watson; J Stjernschantz
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

9.  Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

Authors:  A Alm; J Stjernschantz
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

10.  A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy.

Authors:  D Newsham
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

View more
  2 in total

1.  A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.

Authors:  Daniel M Albert; Ronald E Gangnon; Hans E Grossniklaus; W Richard Green; Soesiawati Darjatmoko; Amol D Kulkarni
Journal:  Arch Ophthalmol       Date:  2008-05

2.  Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.

Authors:  Kazuhide Kawase; Jason L Vittitow; Robert N Weinreb; Makoto Araie
Journal:  Adv Ther       Date:  2016-07-25       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.